Final answer:
The correct response to the student's question about teaching a client receiving chemotherapy and epoetin alfa is C) 'I will monitor my blood pressure regularly,' because epoetin alfa can increase blood pressure, which requires monitoring. Other choices do not directly relate to the understanding of the medication's specific effects.
Step-by-step explanation:
The question concerns a medication called epoetin alfa, which is a synthetic form of the hormone erythropoietin (EPO). EPO is a glycoprotein hormone that stimulates the production of red blood cells (RBCs) by the bone marrow. It is commonly prescribed to treat certain types of anemia, including that caused by chemotherapy.
The correct answer to the student's question is C) "I will monitor my blood pressure regularly." Epoetin alfa can cause an increase in blood pressure, and therefore, it is important for patients receiving this medication to monitor their blood pressure to catch any potential increases early. Choice A is partially correct; while iron supplementation is often necessary when taking epoetin alfa to ensure there are adequate resources for RBC production, the statement alone doesn't show an understanding of the need to monitor blood pressure, a common side effect of epoetin alfa. Choice B is too broad and inaccurate as the medication specifically targets anemia rather than all side effects of chemotherapy. Choice D is unrelated to the specific function of epoetin alfa, although it is good practice for all patients undergoing chemotherapy to report signs of infection.
Regarding the dangers of EPO as a performance-enhancing drug, the answer is A) Erythropoietin increases blood viscosity, which makes it difficult for blood to circulate within the body. Increased RBC counts can lead to high blood viscosity, increasing the risk of heart problems, blood clots, and stroke. This is why EPO is banned in most organized sports.